Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SORRENTO-THERAPEUTICS-INC-14708339/news/Sorrento-Begins-Enrollment-in-Phase-2-Trial-of-Resiniferatoxin-RTX-for-the-Treatment-of-Pain-Due-t-37238979/?utm_source=whatsapp&utm_medium=social&utm_campaign=share